Synopsys, Inc. $SNPS Shares Sold by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 94.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 4,696 shares of the semiconductor company’s stock after selling 75,968 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Synopsys were worth $1,862,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Lombard Odier Asset Management Switzerland SA purchased a new position in Synopsys during the first quarter worth approximately $2,303,000. Waverly Advisors LLC boosted its stake in Synopsys by 2.3% during the first quarter. Waverly Advisors LLC now owns 13,662 shares of the semiconductor company’s stock worth $5,417,000 after buying an additional 306 shares during the period. Maplelane Capital LLC increased its position in shares of Synopsys by 50.9% during the first quarter. Maplelane Capital LLC now owns 123,000 shares of the semiconductor company’s stock valued at $48,767,000 after acquiring an additional 41,500 shares during the last quarter. Entropy Technologies LP purchased a new stake in shares of Synopsys in the 1st quarter valued at approximately $4,258,000. Finally, Broadhurst Jeffrey B purchased a new stake in shares of Synopsys in the 1st quarter valued at approximately $414,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of a number of research analyst reports. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. BNP Paribas Exane boosted their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Wells Fargo & Company upped their price target on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. Finally, Bank of America boosted their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $570.06.

Synopsys Stock Performance

NASDAQ:SNPS opened at $373.47 on Monday. The firm has a market cap of $71.51 billion, a PE ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22. The stock has a fifty day moving average price of $456.13 and a 200 day moving average price of $454.98. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $651.73. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.